We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$365M
AUM Growth
+$83.4M
Cap. Flow
+$53M
Cap. Flow %
14.53%
Top 10 Hldgs %
100%
Holding
13
New
2
Increased
3
Reduced
Closed
4

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$18.3M
2
CMA
Comerica
CMA
+$6.2M
3
CBM
Cambrex Corporation
CBM
+$3.45M

Sector Composition

Rank Sector Weight
1 Healthcare 37.3%
2 Financials 14.37%
3 Technology 12.3%
4 Consumer Discretionary 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$78.8M 21.62%
950,600
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$57.5M 15.77%
+244,000
New +$56.7M
CIT
3
DELISTED
CIT Group Inc.
CIT
$52.4M 14.37%
1,220,857
CCMP
4
CALL
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$49.7M 13.63%
649,000
+145,000
+29% +$9.95M
CCMP
5
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$44.8M 12.3%
585,300
ATRC icon
6
AtriCure
ATRC
$1.7B
$35.5M 9.74%
1,855,000
+769,400
+71% +$13.5M
KATE
7
DELISTED
Kate Spade & Company
KATE
$24.1M 6.62%
1,039,000
+210,000
+25% +$4.39M
CVRS
8
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$14.8M 4.07%
+11,336,154
New +$9.23M
MGLN
9
DELISTED
Magellan Health Services, Inc.
MGLN
$6.82M 1.87%
98,700
CMA
10
DELISTED
Comerica
CMA
-91,000
Closed -$6.2M
THC icon
11
Tenet Healthcare
THC
$16.8B
-1,234,811
Closed -$18.3M
CBM
12
DELISTED
Cambrex Corporation
CBM
-64,000
Closed -$3.45M
CIT
13
CALL
DELISTED
CIT Group Inc.
CIT
-300,000
Closed -$12.8M

Similar funds

Hudson Executive Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Hudson Executive Capital held 13 positions worth $365M, up 30% from $281M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital deployed $53M of net new capital in Q1 2017, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was CORINDUS VASCULAR ROBOTICS, INC: 11,336,154 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 45% a quarter earlier, followed by Financials and Technology.

On the sell side, the most notable exit was Tenet Healthcare, an estimated $18.3M sold.

  • Hudson Executive Capital's largest Q1 2017 buy was CORINDUS VASCULAR ROBOTICS, INC: 11,336,154 shares worth $14.8M.
  • Hudson Executive Capital added most to AtriCure in Q1 2017, an estimated $13.5M increase.
  • Hudson Executive Capital fully exited Tenet Healthcare in Q1 2017, selling an estimated $18.3M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $365M portfolio in Q1 2017.
  • Hudson Executive Capital opened 2 new positions and closed 4 in Q1 2017.
  • Hudson Executive Capital's portfolio value rose 30% quarter-over-quarter to $365M.

Based on Hudson Executive Capital's 13F filing for Q1 2017, filed 15 May 2017.